Kiromic Biopharma Inc. (KRBP): Price and Financial Metrics
GET POWR RATINGS... FREE!
KRBP Stock Price Chart Interactive Chart >
KRBP Price/Volume Stats
| Current price | $0.35 | 52-week high | $11.00 |
| Prev. close | $0.33 | 52-week low | $0.23 |
| Day low | $0.35 | Volume | 95,300 |
| Day high | $0.37 | Avg. volume | 261,353 |
| 50-day MA | $0.64 | Dividend yield | N/A |
| 200-day MA | $1.71 | Market Cap | 5.53M |
Kiromic Biopharma Inc. (KRBP) Company Bio
Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Latest KRBP News From Around the Web
Below are the latest news stories about Kiromic Biopharma Inc that investors may wish to consider to help them evaluate KRBP as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayRise and shine! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, trader! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayGood morning! |
Kiromic BioPharma Announces Changes in Management, Board of DirectorsHOUSTON, February 03, 2022--Kiromic BioPharma Announces Changes in Management, Board of Directors |
Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company’s Board of DirectorsHOUSTON, February 03, 2022--Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company’s Board of Directors |
KRBP Price Returns
| 1-mo | -41.47% |
| 3-mo | -42.74% |
| 6-mo | -87.72% |
| 1-year | -95.73% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -77.12% |
| 2021 | -81.94% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...